Sopharma AD Statistics

Total Valuation

Sopharma AD has a market cap or net worth of PLN 3.80 billion. The enterprise value is 5.04 billion.

Market Cap	3.80B
Enterprise Value	5.04B

Important Dates

The next confirmed earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	Dec 18, 2025

Share Statistics

Current Share Class	525.53M
Shares Outstanding	n/a
Shares Change (YoY)	-30.63%
Shares Change (QoQ)	+41.39%
Owned by Insiders (%)	9.94%
Owned by Institutions (%)	0.29%
Float	181.49M

Valuation Ratios

The trailing PE ratio is 13.18.

PE Ratio	13.18
Forward PE	n/a
PS Ratio	0.67
PB Ratio	1.79
P/TBV Ratio	2.52
P/FCF Ratio	n/a
P/OCF Ratio	94.84
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.36, with an EV/FCF ratio of -88.30.

EV / Earnings	17.49
EV / Sales	0.88
EV / EBITDA	9.36
EV / EBIT	13.39
EV / FCF	-88.30

Financial Position

The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.62.

Current Ratio	1.30
Quick Ratio	0.63
Debt / Equity	0.62
Debt / EBITDA	2.93
Debt / FCF	-23.17
Interest Coverage	6.27

Financial Efficiency

Return on equity (ROE) is 15.52% and return on invested capital (ROIC) is 7.82%.

Return on Equity (ROE)	15.52%
Return on Assets (ROA)	4.35%
Return on Invested Capital (ROIC)	7.82%
Return on Capital Employed (ROCE)	10.89%
Weighted Average Cost of Capital (WACC)	4.41%
Revenue Per Employee	957,881
Profits Per Employee	48,581
Employee Count	5,932
Asset Turnover	1.36
Inventory Turnover	4.19

Taxes

In the past 12 months, Sopharma AD has paid 33.80 million in taxes.

Income Tax	33.80M
Effective Tax Rate	9.96%

Stock Price Statistics

The stock price has increased by +78.43% in the last 52 weeks. The beta is 0.11, so Sopharma AD's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	+78.43%
50-Day Moving Average	8.77
200-Day Moving Average	5.51
Relative Strength Index (RSI)	53.72
Average Volume (20 Days)	614

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sopharma AD had revenue of PLN 5.68 billion and earned 288.18 million in profits. Earnings per share was 0.84.

Revenue	5.68B
Gross Profit	1.35B
Operating Income	291.08M
Pretax Income	339.38M
Net Income	288.18M
EBITDA	443.85M
EBIT	291.08M
Earnings Per Share (EPS)	0.84

Balance Sheet

The company has 154.54 million in cash and 1.32 billion in debt, giving a net cash position of -1.17 billion.

Cash & Cash Equivalents	154.54M
Total Debt	1.32B
Net Cash	-1.17B
Net Cash Per Share	n/a
Equity (Book Value)	2.12B
Book Value Per Share	3.91
Working Capital	538.61M

Cash Flow

In the last 12 months, operating cash flow was 40.04 million and capital expenditures -97.12 million, giving a free cash flow of -57.08 million.

Operating Cash Flow	40.04M
Capital Expenditures	-97.12M
Depreciation & Amortization	153.76M
Net Borrowing	195.96M
Free Cash Flow	-57.08M
FCF Per Share	n/a

Margins

Gross margin is 23.75%, with operating and profit margins of 5.12% and 5.07%.

Gross Margin	23.75%
Operating Margin	5.12%
Pretax Margin	5.97%
Profit Margin	5.07%
EBITDA Margin	7.81%
EBIT Margin	5.12%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.36, which amounts to a dividend yield of 4.27%.

Dividend Per Share	0.36
Dividend Yield	4.27%
Dividend Growth (YoY)	200.38%
Years of Dividend Growth	1
Payout Ratio	10.19%
Buyback Yield	30.63%
Shareholder Yield	34.90%
Earnings Yield	7.59%
FCF Yield	-1.50%

Dividend Details

Stock Splits

The last stock split was on July 10, 2025. It was a forward split with a ratio of 3.

Last Split Date	Jul 10, 2025
Split Type	Forward
Split Ratio	3

Scores

Sopharma AD has an Altman Z-Score of 2.53 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.53
Piotroski F-Score	6